Molecure S.A. (WSE:MOC)
Poland · Delayed Price · Currency is PLN 6.04
+0.22 (3.78%)
Jul 3, 2026, 5:02 PM CET
Molecure Earnings Call Transcripts
Fiscal Year 2024
-
Two main clinical programs advanced: OATD01 (sarcoidosis) with intensified enrollment and OATD02 (solid tumors) with dose escalation. Financials show reduced costs and stable cash, but future funding depends on grants and partnerships, especially for MASH.